alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit
      32** **.1**




**CERTIFICATIONS
      UNDER SECTION 906**




Pursuant
      to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
      and
      (b) of section 1350, chapter 63 of title 18, United States Code), each of the
      undersigned officers of Tutogen Medical Inc., a Florida corporation (the
      "Company"), does hereby certify, to such officer's knowledge, that:




The
      Quarterly Report for the quarter ended March 31, 2007 (the "Form 10-Q") of
      the
      Company fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934, and the information contained in the Form
      10-Q
      fairly presents, in all material respects, the financial condition and results
      of operations of the Company.







Dated:
                May 14, 2007/s/
                Guy L. MayerGuy
                L. MayerChief
                Executive OfficerDated:
                May 14, 2007/s/
                L. Robert Johnston, Jr.L.
                Robert Johnston, Jr.Chief
                Financial Officer










A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.
# C_2022389EN.01001601.xml

| 10.10.2022 | EN | Official Journal of the European Union | C 389/16 |
| --- | --- | --- | --- |

10.10.2022

EN

Official Journal of the European Union

C 389/16

---

Action brought on 22 August 2022 — Bimbo v EUIPO — Bottari Europe (BimboBIKE)

(Case T-509/22)

(2022/C 389/18)

Language in which the application was lodged: English

Parties

Applicant: Bimbo, SA (Madrid, Spain) (represented by: J. Carbonell Callicó, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Bottari Europe Srl (Pomponesco, Italy)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: Application for European Union figurative mark BimboBIKE — Application for registration No 18 274 340

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 16 June 2022 in Case R 2110/2021-1

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | declare inapplicable the order that the applicant bear the costs incurred by the other party to the proceedings before the Board of Appeal; |
| --- | --- |

—

declare inapplicable the order that the applicant bear the costs incurred by the other party to the proceedings before the Board of Appeal;

| — | order EUIPO and the intervening party to pay all the costs of the dispute before the General Court, including those relating to the procedure before the Board of Appeal. |
| --- | --- |

—

order EUIPO and the intervening party to pay all the costs of the dispute before the General Court, including those relating to the procedure before the Board of Appeal.

Pleas in law

| — | Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
| --- | --- |

—

Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

| — | Infringement of Article 109 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
| --- | --- |

—

Infringement of Article 109 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
[Federal Register Volume 62, Number 51 (Monday, March 17, 1997)]
[Notices]
[Page 12649]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6577]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION


Change in Notice of Intent; To Prepare an Environmental Impact 
Statement for the Exterior Security of Federally Occupied Buildings in 
the District of Columbia

    The General Services Administration (GSA) announced its intent to 
prepare an Environmental Impact Statement (EIS) to evaluate the 
potential environmental impacts of vehicle restrictions near selected 
federally-occupied buildings in the District of Columbia in the Federal 
Register on March 6, 1997.
    The public scoping meetings that were scheduled for April 9, 1997 
at the General Services Administration Auditorium located at 18th and F 
Streets NW., Washington, DC and April 10, 1997 at the General Services 
Administration Regional Auditorium located at 7th & D Streets SW., 
Washington, DC 20407 are hereby postponed while the agency collects 
additional data. The new meeting dates will be announced in the Federal 
Register.

    Dated: March 7, 1997.
William R. Lawson,
Assistant Regional Administrator, Public Buildings Service.
[FR Doc. 97-6577 Filed 3-14-97; 8:45 am]
BILLING CODE 6820-23-M
No. 11-10318.

#### Spencer *v.*Thaler, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

C. A. 5th Cir. Certiorari denied.
# C_2022441EN.01002801.xml

| 21.11.2022 | EN | Official Journal of the European Union | C 441/28 |
| --- | --- | --- | --- |

21.11.2022

EN

Official Journal of the European Union

C 441/28

---

Action brought on 3 October 2022 — Breville v EUIPO (Cooking devices)

(Case T-616/22)

(2022/C 441/38)

Language of the case: English

Parties

Applicant: Breville Pty Ltd (Alexandria, Australia) (represented by: F. Caruso, G. Grippiotti, M. Pozzi, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO

Design: Community design No 1 444 467-0001

Contested decision: Decision of the Third Board of Appeal of EUIPO of 20 June 2022 in Case R 613/2022-3

Form of order sought

The applicant claims that the Court should annul the contested decision and grant the requested restitutio in integrum.

Pleas in law

| — | Error in law in connection with the time limit to file the application for restitutio in integrum; |
| --- | --- |

—

Error in law in connection with the time limit to file the application for restitutio in integrum;

| — | Infringement of Article 67(1) of Council Regulation (EC) No 6/2002. |
| --- | --- |

—

Infringement of Article 67(1) of Council Regulation (EC) No 6/2002.

---
**UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549**

----

**FORM 10-Q**

----

**[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2002

OR
**[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934**

Commission File Number 0-18952

**NTS-PROPERTIES PLUS LTD.**

Incorporated pursuant to the Laws of the State of Florida

Internal Revenue Service - Employer Identification No. 61-1126478

10172 Linn Station Road, Louisville, Kentucky 40223

(502) 426-4800

Indicate by check mark whether the registrant  (1) has filed all reports  required to be filed by Section 13 or 15(d) of the SecuritiesExchange  Act of 1934  during the  preceding  12 months (or for such  shorter  period  that the  registrant  was  required to file suchreports) and (2) has been subject to such filing requirements for the past 90 days.               Yes |X|      No  |   |

State the aggregate market value of the voting and non-voting common equity held by non-affiliatescomputed by reference to the price at which the common equity was sold, or the average bid andasked price of such common equity, as of a specified date within the past 60 days: No aggregatemarket value can be determined because no established market exists for the limited partnershipInterests.

**TABLE OF CONTENTS**

**PART I**
Pages Item 1.Financial Statements Balance Sheets as of March 31, 2002 and December 31, 20013 Statement of Partners' Deficit as of March 31, 20023 Statements of Operations for the Three Months    Ended March 31, 2002 and 20014  Statements of Cash Flows for the Three Months    Ended March 31, 2002 and 20015  Notes to Financial Statements6-10  Item 2.Management's Discussion and Analysis of Financial    Condition and Results of Operations11-15  Item 3.Quantitative and Qualitative Disclosures About Market Risk16  
**PART II**
  Item 1.Legal Proceedings17  Item 2.Changes in Securities17  Item 3.Defaults Upon Senior Securities17  Item 4.Submission of Matters to a Vote of Security Holders17  Item 5.Other Information17  Item 6.Exhibits and Reports on Form 8-K17  Signatures18
2

**PART I - FINANCIAL INFORMATION**
# C_2022207EN.01001802.xml

| 23.5.2022 | EN | Official Journal of the European Union | C 207/18 |
| --- | --- | --- | --- |

23.5.2022

EN

Official Journal of the European Union

C 207/18

---

Request for a preliminary ruling from the Conseil d’État (France) lodged on 1 March 2022 — Association Avocats pour la défense des droits des étrangers (ADDE) and Others v Ministre de l’Intérieur

(Case C-143/22)

(2022/C 207/26)

Language of the case: French

Referring court

Conseil d’État

Parties to the main proceedings

Applicants: Association Avocats pour la défense des droits des étrangers (ADDE), Association nationale d’assistance aux frontières pour les étrangers (ANAFE), Association de recherche, de communication et d’action pour l’accès aux traitements (ARCAT), Comité inter-mouvements auprès des évacués (CIMADE), Fédération des associations de solidarité avec tou-te-s les immigré-e-s (FASTI), Groupe d’information et de soutien des immigré.e.s (GISTI), Ligue des droits de l’homme (LDH), Le Paria, Syndicat des avocats de France (SAF), SOS — Hépatites Fédération

Defendant: Ministre de l’Intérieur

Question referred

In the event of the temporary reintroduction of border controls at internal borders, under the conditions laid down in Chapter II of Title III of Regulation (EU) 2016/399, (1) can foreign nationals arriving directly from the territory of a State party to the Schengen Convention signed on 19 June 1990 be refused entry, when entry checks are carried out at that border, on the basis of Article 14 of that regulation, without Directive 2008/115/EC (2) being applicable?

---

(1)  Regulation (EU) 2016/399 of the European Parliament and of the Council of 9 March 2016 on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code) (OJ 2016 L 77, p. 1).

(2)  Directive 2008/115/EC of the European Parliament and of the Council of 16 December 2008 on common standards and procedures in Member States for returning illegally staying third-country nationals (OJ 2008 L 348, p. 98).

---
# C_2023083EN.01002401.xml

| 6.3.2023 | EN | Official Journal of the European Union | C 83/24 |
| --- | --- | --- | --- |

6.3.2023

EN

Official Journal of the European Union

C 83/24

---

Judgment of the General Court of 21 December 2022 — OM v Commission

(Case T-118/22) (1)

(Civil service - Members of the temporary staff - Recruitment - Vacancy notice - Rejection of application - Appointment of another candidate - Position of Member of the Regulatory Scrutiny Board - Obligation to state reasons - Infringement of the vacancy notice - Legitimate expectation - Equal treatment - Manifest error of assessment)

(2023/C 83/29)

Language of the case: French

Parties

Applicant: OM (represented by: G. Paris, lawyer)

Defendant: European Commission (represented by: I. Melo Sampaio and A.-C. Simon, acting as Agents)

Re:

By his action under Article 270 TFEU, the applicant seeks annulment of the decision of 29 April 2021 by which the European Commission rejected his application for the position of Member of the Regulatory Scrutiny Board and informed him of the appointment of another candidate to that position.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders OM to pay the costs. |
| --- | --- |

2.

Orders OM to pay the costs.

---

(1)  OJ C 191, 10.5.2022.

---
### IN THE SUPREME COURT OF THE STATE OF MONTANA DA 22 - 0132

_________________ ST ATE OF MONTANA,

Plaintiff and Appellee, v. MATTHEW ROBERT ALLEN,

Defendant and Appellant. O R D E R

_________________ Upon consideration of Appellant Matthew Robert Allen’s Motion for Extension of Time and good cause appearing therefore, Allen is GRANTED an extension of time within which to file his Reply Brief to and including July 6 , 2023. No further extensions will be granted.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

June 15 2023

06/15/2023
Case Number: DA 22-0132
##### 



EXHIBIT 24.1
 
    Signature
    
    Title/s/ Phillip L. FriedmanPhillip L. Friedman
    
    Chairman and Director/s/ William J. BergenWilliam J. Bergen
    
    President, Chief Executive Officer and Director/s/ Jeffrey ShapiroJeffrey Shapiro
    
    Chief Financial and Accounting Officer/s/ John F. TurbenJohn F. Turben
    
    Director/s/ John G. NestorJohn G. Nestor
    
    Director/s/ Michael SherwinMichael Sherwin
    
    Director/s/ Michael LynchMichael Lynch
    
    Director/s/ Matthew SheppardMatthew Sheppard
    
    Director
No. 11-10740.

#### Holston *v.*Tucker, Secretary, Florida Department of Corrections.

C. A. 11th Cir. Certiorari denied.
Exhibit 10.2(e)


 


February 19, 2014


[Debenture Holder’s Name]


 


Re: Amended and Restated 8% Convertible
Debenture Conversion Letter Agreement


 


Dear ____:


 


We are offering holders of the Innovus
Pharmaceuticals, Inc. (“Innovus” or the “Company”) Amended and Restated 8% Convertible Debenture, dated
November 11, 2013 (the “Debenture”), with the opportunity to do a one-time conversion of the outstanding principal
and interest under the Debenture at a conversion rate of $0.40 per share of common stock of the Company.


 


If you would like to
participate in this conversion process, please (1) sign this letter agreement below and (2) please surrender the Debenture, appropriately
endorsed to us at 9171 Towne Centre Drive, Suite 440, San Diego, CA 92122 accompanied by your written notice to us setting forth
the names or names (with addresses(es)) in which the common stock of Innovus shall be issued and registered on the books of the
Company. The Debenture shall be marked cancelled on the books of the Company as of the date hereof, whether or not surrendered.


 


As of the date hereof, the principal and
accrued interest under the Debenture is $______ and will convert into ______ shares of our common stock.


 


If you would like to convert into shares
of the Company’s common stock as described above, please sign below.


 


Once you convert as described herein, your
Debenture will terminate in its entirety as of the date hereof.


 


Please scan this document back to me at
ldillen@innovuspharma.com or fax it back to us at 858-356-9452.


 


Kind Regards,


 


/s/LYNNETTE DILLEN


 


Lynnette Dillen


Executive Vice President, Chief Financial Officer


Innovus Pharmaceuticals, Inc.


 


I, hereby, agree to be bound by the terms and conditions of
this letter agreement:


 


_________________________________


[Debenture Holder’s name]


 


cc. Dr. Bassam Damaj


President and CEO


 


Randy Berholtz, Esq.


Acting General Counsel and Secretary


 



    	1



    	 



    

 


Schedule of Debenture
Holders


 


This schedule is being
provided pursuant to Item 601 of Regulation S-K.


 


	 	 	Outstanding Principal	 	 	 	 	 	Original Principal Amount	 
	Name of Holder	 	and Interest ($)	 	 	Common Stock Issued	 	 	(in U.S. dollars)	 
	 	 	 	 	 	 	 	 	 	 
	Wallace T. Boyack	 	$	87,219	 	 	 	218,048	 	 	$	74,667	 
	Vivian Liu	 	$	58,405	 	 	 	146,014	 	 	$	50,000	 
	Walid Chehab	 	$	23,362	 	 	 	58,405	 	 	$	20,000	 
	Henry Esber, PhD. (2102)	 	$	15,185	 	 	 	37,964	 	 	$	13,000	 
	Henry Esber, PhD. (2013)	 	$	76,122	 	 	 	190,304	 	 	$	70,000	 
	Ziad Mirza	 	$	5,841	 	 	 	14,601	 	 	$	5,000	 
	Bassam Damaj	 	$	476,165	 	 	 	1,190,411	 	 	$	452,728	 



 




    	2
# C_2022408EN.01003802.xml

| 24.10.2022 | EN | Official Journal of the European Union | C 408/38 |
| --- | --- | --- | --- |

24.10.2022

EN

Official Journal of the European Union

C 408/38

---

Action brought on 2 September 2022 — Sanity Group v EUIPO — AC Marca Brands (Sanity Group)

(Case T-541/22)

(2022/C 408/51)

Language in which the application was lodged: English

Parties

Applicant: Sanity Group GmbH (Berlin, Germany) (represented by: B. Koch and V. Wolf, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: AC Marca Brands, SL (Barcelona, Spain)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union figurative mark Sanity Group — Application for registration No 18 110 653

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 22 June 2022 in Case R 2107/2021-1

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Plea in law

| — | Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
| --- | --- |

—

Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Galaxy Nutritional Foods, Inc. (the
"Company") on Form 10-Q for the period ended September 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Salvatore J. Furnari, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of Section 13(a) or
      15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.

                                        /s/ Salvatore J. Furnari
                                        ----------------------------------------
                                        Salvatore J. Furnari
                                        Chief Financial Officer
                                        November 15, 2004
EX-10.10(c)



 Exhibit 10.10(c) 
 June 1, 2013 
 Willowbridge Associates Inc. 

101 Morgan Lane - Suite 180 
 Plainsboro, N.J.
08536 
 Attention: Mr. Steve R. Crane 
  

	 	Re:	Management Agreement Renewals 

 Dear
Mr. Crane: 
 We are writing with respect to your management agreements concerning the commodity pools to which reference is made below
(the “Management Agreements”). We are extending the term of the Management Agreements through June 30, 2014 and all other provisions of the Management Agreements will remain unchanged. 

 

	 	•	 	 Diversified Multi-Advisor Futures Fund L.P. 



	 	•	 	 Diversified Multi-Advisor Futures Fund L.P. II 



	 	•	 	 Tactical Diversified Futures Fund L.P. 



	 	•	 	 CMF Willowbridge Master Fund L.P. 



	 	•	 	 Emerging CTA Portfolio LP 



Please acknowledge receipt of this modification by signing one copy of this letter and returning it to the attention of Mr. Damian George at the
address above or fax to 212-296-6868. If you have any questions I can be reached at 212-296-1292. 
 Very truly yours, 

 

			
	CERES MANAGED FUTURES LLC
		
	By:	 	/s/ Damian George
		 	Damian George
		 	Chief Financial Officer & Director
	
	WILLOWBRIDGE ASSOCIATES INC.
		
	By:            	 	/s/ Steven R. Crane


			
		
	 Print Name:
	 	Steven R. Crane
		
	DG/sr
# C_2023223EN.01001702.xml

| 26.6.2023 | EN | Official Journal of the European Union | C 223/17 |
| --- | --- | --- | --- |

26.6.2023

EN

Official Journal of the European Union

C 223/17

---

Order of the President of the Court of 27 February 2023 (request for a preliminary ruling from the Verwaltungsgerichtshof — Austria) — AB v Disziplinarrat der Österreichischen Apothekerkammer, interested party: Bundesminister für Soziales, Gesundheit, Pflege und Konsumentenschutz

(Case C-417/22, (1) Disziplinarrat der Österreichischen Apothekerkammer)

(2023/C 223/23)

Language of the case: German

The President of the Court has ordered that the case be removed from the register.

---

(1)  OJ C 326, 29.8.2022.

---
## MD4 - 3000 SPECIFICATIONS

**Technical drawing md4 -**  **3000 (PD F)** 

• Rate of climb: 10 m/s

• Operating speed: 16.0 m/s

• Maximum thrust: 280 N

• Weight: ca. 10,400 g (depending on configuration)

• Recommended load: 3,000 g

• Maximum load: 4,000 g• Maximum take - off weight (MTOW): 15,000 g

• Dimensions: 2052 mm x 1888 mm (from rotor hu b to rotor hub)

• Flying time: up to 45 minutes (depending on load / wind / battery)

• Battery: 6S2P LiPo, 22.2V, 13000mAh

• Flat core motors: yes

• CFD optimised propeller: yes

• Closed carbon housing: yes

• IP43 protection: yes

• Temperature: - 10 bis 50 °C

• Humidity: max 90% r.H.

• Wind susceptibility: vibration - free images up to 6 m/s

• Flight range: min. 500 m with remote control, with WP up to 50 km

• Service ceiling: 4,000m ASL

• Start altitude: up to 4,000 m NN (WGS84)